A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.
About This Bill
Committee
Latest Action · June 11, 2019
Read twice and referred to the Committee on Finance.